Intelligent Supplier Selection and Disruption-Resilient Pharmaceutical Distribution Network Design: A Data-Driven Hybrid Framework

Authors

https://doi.org/10.22105/ahse.vi.60

Abstract

The selection of an appropriate supplier in the pharmaceutical supply chain plays a crucial role in reducing costs, ensuring quality, and enhancing the resilience of the network due to the high sensitivity and the need for timely delivery of medications. The complexities and uncertainties within this chain further necessitate the use of innovative, data-driven approaches for supplier selection and decision-making improvement. In this study, a combined data-driven framework for supplier selection and pharmaceutical distribution network design under uncertainty is presented. Initially, key criteria were dynamically identified using a decision tree algorithm based on real-world supplier data, and then weighted using the Analytic Hierarchy Process (AHP). Subsequently, supplier ranking was performed using an improved version of the CoCoSo method, named CoCoFISo, which, by refining the normalization process and redefining the aggregation strategy, resulted in higher accuracy and stability compared to conventional methods. Finally, the outcomes of these stages were integrated into a two-stage stochastic optimization model to simultaneously optimize three objectives: minimizing total cost, maximizing supplier scores, and maximizing supply chain reliability. The implementation of the model on real-world data demonstrated that the proposed approach, especially the use of CoCoFISo, outperformed the TOPSIS and CoCoSo methods. This superiority was particularly evident in cost reduction, improved supplier selection, and increased resilience of the pharmaceutical network. The proposed framework can serve as an effective tool for decision-makers in the pharmaceutical industry to design sustainable and resilient networks capable of coping with demand fluctuations and operational disruptions.

Keywords:

Supplier selection, Decision tree, Analytic hierarchy process, Pharmaceutical supply chain, Machine learning

References

  1. [1] Abdulla, A., & Baryannis, G. (2024). A hybrid multi-criteria decision-making and machine learning approach for explainable supplier selection. Supply chain analytics, 7, 100074. https://doi.org/10.1016/j.sca.2024.100074

  2. [2] Serrano, D. R., Luciano, F. C., Anaya, B. J., Ongoren, B., Kara, A., Molina, G., … Lalatsa, A. (2024). Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine. Pharmaceutics, 16(10). DOI:10.3390/pharmaceutics16101328

  3. [3] Bottani, E., Nardo, M. Di, Monferdini, L., & Murino, T. (2025). Mapping LARGS criteria and relationships for supplier selection using a fuzzy hybrid approach. Computers & industrial engineering, 206, 111252. DOI:https://doi.org/10.1016/j.cie.2025.111252

  4. [4] Forghani, A., Sadjadi, S. J., & Moghadam, B. F. (2018). A supplier selection model in pharmaceutical supply chain using PCA, Z-TOPSIS and MILP: A case study. PLoS one, 13(8), 1–17. DOI:10.1371/journal.pone.0201604

  5. [5] Sheykhizadeh, M., Ghasemi, R., Vandchali, H. R., Sepehri, A., & Torabi, S. A. (2024). A hybrid decision-making framework for a supplier selection problem based on lean, agile, resilience, and green criteria: a case study of a pharmaceutical industry. Environment, development and sustainability, 26(12), 30969–30996. https://doi.org/10.1007/s10668-023-04135-7

  6. [6] Pourghahreman, N., & Rajabzadeh Qhatari, A. (2015). Supplier selection in an agent based pharmaceutical supply chain: An application of TOPSIS and PROMETHEE II. Uncertain supply chain management, 3(3), 231–240. DOI:10.5267/j.uscm.2015.4.001

  7. [7] Mehralian, G., Gatari, A. R., Morakabati, M., & Vatanpour, H. (2012). Developing a suitable model for supplier selection based on supply chain risks: An empirical study from Iranian pharmaceutical companies. Iranian journal of pharmaceutical research, 11(1), 209–219.

  8. [8] Modibbo, U. M., Hassan, M., Ahmed, A., & Ali, I. (2022). Multi-criteria decision analysis for pharmaceutical supplier selection problem using fuzzy TOPSIS. Management decision, 60(3), 806–836. DOI:10.1108/MD-10-2020-1335

  9. [9] Kayani, S. A., Warsi, S. S., & Liaqait, R. A. (2023). A Smart Decision Support Framework for Sustainable and Resilient Supplier Selection and Order Allocation in the Pharmaceutical Industry. Sustainability (switzerland), 15(7). DOI:10.3390/su15075962

  10. [10] Purnomo Putro, D., Eka Suryani, P., & Amri, S. (2025). Comparative Analysis of AHP, SAW, TOPSIS, VIKOR, and MABAC in Pharmaceutical Supplier Selection. Jurnal transformatika, 23(1), 1–11. DOI:10.26623/transformatika.v23i1.12220

  11. [11] Chakraborty, S., Raut, R. D., Rofin, T. M., & Chakraborty, S. (2024). On solving a healthcare supplier selection problem using MCDM methods in intuitionistic fuzzy environment. OPSEARCH, 61(2), 680–708. DOI:10.1007/s12597-023-00733-1

  12. [12] Raveena, R., & Umamaheswari, S. (2025). Integrated MCDM framework for sustainable pharmacy supplier selection using pioneering criteria with fuzzy TOPSIS SVR and GRA. Scientific reports, 15(1), 1–25. DOI:10.1038/s41598-025-02975-z

  13. [13] Siddiquee, M. M., Shaha, P., & Hasin, A. (2024). Greening the pillars of pharmaceuticals: Sustainable supplier selection in emerging economies. Journal of future sustainability, 4, 159–168. DOI:10.5267/j.jfs.2024.9.001

  14. [14] Gidiagba, O. J., Tartibu, L., & Okwu, M. (2025). Integrating Machine Learning with Multi-Criteria Decision-Making Models for Sustainable Supplier Selection in Dynamic Supply Chains. Logistics, 9(4). DOI:10.3390/logistics9040152

  15. [15] Lo, H.-W., Chi, C.-Y., Pai, C.-J., & Deveci, M. (2026). A data-driven two-stage decision-making model for supplier selection and negotiation-based procurement planning. International journal of production research, 64(1), 39–62. DOI:10.1080/00207543.2025.2539305

  16. [16] Momena, A. F., Gazi, K. H., & Mondal, S. P. (2025). Multi-Criteria Decision Analysis for Sustainable Medicinal Supply Chain Problems with Adaptability and Challenges Issues. Logistics, 9(1), 1–32. DOI:10.3390/logistics9010031

  17. [17] Rahbar, E., Ghorbani Chenarlogh, A., Mohammadsalehi, R., & Zanjirchi, S. M. (2026). Evaluating digital twin adoption for sustainable supply chains in pharma: a fuzzy MEREC–TOPSIS approach. Environment systems and decisions, 46(3), 36. DOI:10.1007/s10669-026-10097-8

  18. [18] Wyrembek, M., Baryannis, G., & Brintrup, A. (2025). Causal machine learning for supply chain risk prediction and intervention planning. International journal of production research, 63(15), 5629–5648. DOI:10.1080/00207543.2025.2458121

Published

2026-07-07

Issue

Section

Articles

How to Cite

Amou Jafari, A., Sharifi Nik, M., & Foroozanfar, A. (2026). Intelligent Supplier Selection and Disruption-Resilient Pharmaceutical Distribution Network Design: A Data-Driven Hybrid Framework. Annals of Healthcare Systems Engineering. https://doi.org/10.22105/ahse.vi.60

Similar Articles

11-20 of 32

You may also start an advanced similarity search for this article.